The growing adoption of GLP-1 therapies is beginning to influence a market far beyond pharmaceuticals. Beauty is becoming part of this conversation - not because GLP-1 is creating a new cosmetic category, but because significant weight loss can change consumer needs related to skin, body and hair care.
The widely discussed “Ozempic face” is probably the most visible part of this phenomenon. From an R&D perspective, however, its implications may be much broader.
From weight loss to new beauty needs
GLP-1 receptor agonist therapies have become one of the most widely discussed developments in health and wellness. As their use continues to grow, the beauty industry is beginning to observe changing expectations and concerns among a growing group of consumers.
Significant or rapid weight loss can be associated with changes in facial volume, increased skin laxity and changes in facial contours and skin appearance. Loss of subcutaneous fat may become particularly noticeable around the cheeks, temples and lower face - contributing to the appearance commonly described as “Ozempic face”.
But the face is only one part of a much broader picture.
Changes in body composition may increase consumer interest in products focused on skin quality, elasticity, hydration and the appearance of firmness. At the same time, emerging evidence and observations point to increased hair shedding in some people experiencing significant weight loss, although the mechanisms behind this phenomenon are still being investigated.
Factors accompanying rapid weight reduction - including changes in nutrition, calorie restriction and physiological stress - may also play a role.
From a beauty industry perspective, this raises a much more interesting question:
What happens when a major shift in health and lifestyle begins to influence the needs that cosmetic products are expected to address?
Beyond “Ozempic face”
Reducing the impact of GLP-1 to changes in facial volume alone risks overlooking a much broader shift.
We may be seeing growing relevance across several areas of beauty: skincare focused on hydration, barrier support, elasticity and the appearance of firmness; more advanced body care; hair and scalp care addressing concerns around shedding and thinning; and cosmetic products designed to complement professional and aesthetic procedures.
This does not necessarily mean developing products specifically labelled as “cosmetics for GLP-1 users”.
From a product development perspective, the more interesting opportunity is to understand the underlying needs and translate them into solutions with broader relevance.
This is where cosmetic R&D and formulation development at MG Evolution becomes particularly important - from defining the consumer need and designing the formulation architecture to ingredient selection, sensory profile, testing strategy and appropriate product claims.
A shift in consumer needs with business implications
The significance of this phenomenon is also becoming visible in market data.
According to McKinsey’s State of Beauty 2026, GLP-1 households are estimated to spend approximately 30% more on beauty products than non-GLP-1 households.
This is an important signal for the market.
The growing adoption of GLP-1 therapies does not necessarily mean consumers are reducing their interest in beauty. Instead, changes in appearance, body composition and personal-care priorities may influence which products consumers choose to spend on and what they increasingly expect those products to deliver.
For beauty brands, this means GLP-1 may become more than a temporary topic dominating social media conversations.
It may begin to influence new product briefs.
What could GLP-1 mean for cosmetic product development?
The first area is overall skin quality.
Rather than focusing exclusively on conventional anti-ageing communication, formulation development may increasingly address hydration, barrier function, skin comfort, elasticity and the appearance of firmness. This creates opportunities to build more comprehensive formulation strategies combining barrier-supporting ingredients, humectants, lipids, peptides and other actives - always selected around a clearly defined product objective.
The second area is body care.
Body care is increasingly moving beyond basic moisturisation. Changes associated with significant weight loss may further increase demand for more advanced formulations, active ingredients and product concepts focused on skin condition, elasticity and appearance.
The third area is hair and scalp care.
If concerns around increased shedding or thinning become more visible among consumers experiencing significant weight changes, scalp care may gain even greater importance. Responsible product development, however, requires a clear distinction between cosmetic support and medical claims, with products designed around benefits that can be realistically and reliably substantiated.
A fourth area is the growing connection between cosmetics and aesthetic medicine.
Consumers experiencing changes in facial volume or skin appearance may increasingly combine at-home skincare with professional treatments. This creates space for products designed around the entire treatment journey - from skin preparation and barrier support to soothing, recovery and long-term skin-quality maintenance.
For brands exploring these opportunities, Private Label and comprehensive product development at MG Evolution can cover the entire process - from concept and formulation development through testing and scale-up to manufacturing the finished cosmetic product.
The opportunity is not to create a “GLP-1 beauty” category
Every significant shift in consumer behaviour quickly generates new marketing terminology. “GLP-1 beauty” could easily become another example.
From an R&D perspective, however, creating another temporary category is less interesting than understanding the more structural change behind it.
The question for beauty brands should therefore not be:
Should we develop a cosmetic product for GLP-1 users?
A more important question is:
Which beauty needs are becoming more relevant as consumer lifestyles, health behaviours and expectations change?
That distinction matters.
It moves the conversation from a marketing trend to product strategy.
What should beauty R&D watch next?
GLP-1 demonstrates how quickly developments outside the cosmetics industry can begin to influence product development.
Pharmaceutical innovation, changing nutrition patterns, longevity, aesthetic medicine and new approaches to metabolic health are increasingly connected with the way consumers think about their skin, hair and body.
For R&D teams, this means market intelligence can no longer focus exclusively on new cosmetic ingredients or competitor launches.
Developing the next generation of products increasingly requires understanding what is changing around the consumer - and how those changes are influencing their needs.
GLP-1 is one example.
The products developed in response to the needs emerging from this shift may ultimately become the much more interesting story.